Observational studyClinical rheumatology2018

Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial.

Violetta Opoka-Winiarska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.